Due to the limited data presented in the published papers, only some of the immunological assessments, e.g., Ag-NORs (argyrophilic nucleolar organizer regions), and NSCLC tumor markers, e.g., CEA, were subjected to analysis. This evidence concerns the gene CEACAM5 and non-small cell lung carcinoma.